Evidence map›Paper›PMID 37228849›Full record

ArticleTrauma case reports2023

The use of 3D printing technology in limb reconstruction. Inspirations and challenges.

Efthymios Iliopoulos, Konstantinos Makiev, Paraskevas Georgoulas, Nick Vordos, Athanasios Ververidis, Konstantinos Tilkeridis

Open access · goldAbstract readCase Reports
In one paragraph

Article in Trauma case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Efthymios IliopoulosTrauma and Orthopaedics Department, Alexandroupolis University Hospital, University of Thrace, Alexandroupolis, Greece.
Konstantinos MakievTrauma and Orthopaedics Department, Alexandroupolis University Hospital, University of Thrace, Alexandroupolis, Greece.
Paraskevas GeorgoulasTrauma and Orthopaedics Department, Alexandroupolis University Hospital, University of Thrace, Alexandroupolis, Greece.
Nick VordosBiophysics Laboratory, Physics Department, International Hellenic University, Kavala, Greece.
Athanasios VerveridisTrauma and Orthopaedics Department, Alexandroupolis University Hospital, University of Thrace, Alexandroupolis, Greece.
Konstantinos TilkeridisTrauma and Orthopaedics Department, Alexandroupolis University Hospital, University of Thrace, Alexandroupolis, Greece.
University Hospital of Alexandroupolis · GRInternational Hellenic University · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The management of septic non-unions with associated bone necrosis is challenging, especially when the resulting bone defect after the debridement is extensile. Different techniques have been described in the literature for the treatment of these demanding cases, with the most prominent being free vascularized Fibular graft and bone transport with distraction osteogenesis principles. Recently, 3D printing technology has been increasingly utilized in many complex orthopaedic pathologies. However, the application of those advancements regarding septic non-unions with residual bone defect has not been previously studied. This study presents a novel 3D printing technique for the management of an infected critical bone deficit of the tibia. Queries, challenges and future perspectives concerning the recruiting of 3D printing technology in limb reconstruction are also being discussed. Clinical Evidence Level: IV.

Indexed as

Ankle arthrodesisBone transportSeptic non-unionThree dimension printing

Identifiers

PMID37228849
PMCPMC10203763
OpenAlexW4376651005

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.